FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2015964974> ?p ?o ?g. }

• W2015964974 endingPage "319" @default.
• W2015964974 startingPage "319" @default.
• W2015964974 abstract "This prospective, randomized, double-masked, placebo-controlled, parallel-group study assessed the safety and efficacy of 2 dosage regimens of once-daily metrifonate in patients with probable Alzheimer's disease (AD) of mild-to-moderate severity. A total of 395 patients were randomized to receive placebo (n = 134) or metrifonate in 1 of 2 regimens. The loading-dose group (n = 133) received a daily loading dose of metrifonate 100 mg or 150 mg (by weight) for 2 weeks, followed by a daily maintenance dose of metrifonate 50 mg for 4 weeks; the no-loading-dose group (n = 128) received the daily maintenance dose of metrifonate 50 mg for 6 weeks. The primary measure of efficacy was the Alzheimer's Disease Assessment Scale—Cognitive Subscale (ADAS-Cog); secondary measures of efficacy included the Mini-Mental State Examination (MMSE), the Clinician's Interview Based Impression of Change with Caregiver Input (CIBIC-Plus), the Clinician's Interview Based Impression of Severity with Caregiver Input (CIBIS-Plus), and the ADAS—Noncognitive Subscale (ADAS-Noncog). Safety was assessed by the prevalence of premature study termination and treatment-emergent adverse events, as well as by changes in vital signs, findings on electrocardiographic and neurologic examinations, and abnormalities on laboratory tests. At 4 weeks of treatment, defined by the protocol as the target efficacy determination, the mean ADAS-Cog scores of the intent-to-treat population (last observation carried forward) favored the loading-dose group versus the placebo group, but the difference was not statistically significant. However, at week 6, the difference in mean ADAS-Cog scores was statistically significant compared with placebo. At neither week 4 nor week 6 was there a statistically significant difference in the mean ADAS-Cog scores of the no-loading-dose and placebo groups. For the CIBIC-Plus, the treatment difference between the placebo and loading-dose groups significantly favored metrifonate at week 6 but not at week 4, whereas the treatment difference between the placebo and no-loading-dose groups was statistically significant at both time points. For the MMSE, CIBIS-Plus, and ADAS-Noncog, treatment differences for both groups versus placebo did not reach statistical significance at either week 4 or 6. Assessment of the frequency of adverse events in metrifonate-treated patients revealed that the no-loading-dose regimen was better tolerated than the loading-dose regimen. Given the overall similar efficacy and more favorable safety profile associated with the no-loading-dose regimen versus the loading-dose regimen observed in mis study, the no-loading-dose regimen appears to be the better strategy for initiating metrifonate treatment in patients with probable AD of mild-to-moderate severity." @default.
• W2015964974 created "2016-06-24" @default.
• W2015964974 creator A5006136213 @default.
• W2015964974 creator A5011029002 @default.
• W2015964974 creator A5013478589 @default.
• W2015964974 creator A5028387948 @default.
• W2015964974 creator A5043518483 @default.
• W2015964974 creator A5052099394 @default.
• W2015964974 creator A5077236923 @default.
• W2015964974 creator A5084209151 @default.
• W2015964974 date "1999-09-01" @default.
• W2015964974 modified "2023-09-27" @default.
• W2015964974 title "Down's syndrome patients: Alzheimer-like implication of the immune system?" @default.
• W2015964974 doi "https://doi.org/10.1016/s0924-977x(99)80433-7" @default.
• W2015964974 hasPublicationYear "1999" @default.
• W2015964974 type Work @default.
• W2015964974 sameAs 2015964974 @default.
• W2015964974 citedByCount "0" @default.
• W2015964974 crossrefType "journal-article" @default.
• W2015964974 hasAuthorship W2015964974A5006136213 @default.
• W2015964974 hasAuthorship W2015964974A5011029002 @default.
• W2015964974 hasAuthorship W2015964974A5013478589 @default.
• W2015964974 hasAuthorship W2015964974A5028387948 @default.
• W2015964974 hasAuthorship W2015964974A5043518483 @default.
• W2015964974 hasAuthorship W2015964974A5052099394 @default.
• W2015964974 hasAuthorship W2015964974A5077236923 @default.
• W2015964974 hasAuthorship W2015964974A5084209151 @default.
• W2015964974 hasConcept C126322002 @default.
• W2015964974 hasConcept C142724271 @default.
• W2015964974 hasConcept C168563851 @default.
• W2015964974 hasConcept C197934379 @default.
• W2015964974 hasConcept C204787440 @default.
• W2015964974 hasConcept C27081682 @default.
• W2015964974 hasConcept C2776000289 @default.
• W2015964974 hasConcept C2776890885 @default.
• W2015964974 hasConcept C2908647359 @default.
• W2015964974 hasConcept C42219234 @default.
• W2015964974 hasConcept C71924100 @default.
• W2015964974 hasConcept C99454951 @default.
• W2015964974 hasConceptScore W2015964974C126322002 @default.
• W2015964974 hasConceptScore W2015964974C142724271 @default.
• W2015964974 hasConceptScore W2015964974C168563851 @default.
• W2015964974 hasConceptScore W2015964974C197934379 @default.
• W2015964974 hasConceptScore W2015964974C204787440 @default.
• W2015964974 hasConceptScore W2015964974C27081682 @default.
• W2015964974 hasConceptScore W2015964974C2776000289 @default.
• W2015964974 hasConceptScore W2015964974C2776890885 @default.
• W2015964974 hasConceptScore W2015964974C2908647359 @default.
• W2015964974 hasConceptScore W2015964974C42219234 @default.
• W2015964974 hasConceptScore W2015964974C71924100 @default.
• W2015964974 hasConceptScore W2015964974C99454951 @default.
• W2015964974 hasLocation W20159649741 @default.
• W2015964974 hasOpenAccess W2015964974 @default.
• W2015964974 hasPrimaryLocation W20159649741 @default.
• W2015964974 hasRelatedWork W1490315633 @default.
• W2015964974 hasRelatedWork W2030308013 @default.
• W2015964974 hasRelatedWork W2041904666 @default.
• W2015964974 hasRelatedWork W2042706422 @default.
• W2015964974 hasRelatedWork W2121788441 @default.
• W2015964974 hasRelatedWork W2313075965 @default.
• W2015964974 hasRelatedWork W2588249775 @default.
• W2015964974 hasRelatedWork W2889241372 @default.
• W2015964974 hasRelatedWork W3216898030 @default.
• W2015964974 hasRelatedWork W4283171304 @default.
• W2015964974 hasVolume "9" @default.
• W2015964974 isParatext "false" @default.
• W2015964974 isRetracted "false" @default.
• W2015964974 magId "2015964974" @default.
• W2015964974 workType "article" @default.